Evidence map›Paper›PMID 31818335›Full record

ArticleThe British journal of nutrition2020

New approach to simplifying and optimising acute malnutrition treatment in children aged 6-59 months: the OptiMA single-arm proof-of-concept trial in Burkina Faso.

Maguy Daures, Kevin Phelan, Mariama Issoufou, Séni Kouanda, Ousmane Sawadogo, Kader Issaley, Cecile Cazes, Benjamin Séri, Bertine Ouaro, Bruno Akpakpo and 3 more

3 registry-linked trialsAbstract read
In one paragraph

Article in The British journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06287827 completednot on this mapstarted 2024, after this paper: background citation

Evaluation of the Treatment of Moderate and Severe Acute Malnutrition in Outpatient Care Services in Venezuela: a Multicentric and Prospective Cohort Research

TypeobservationalSponsorUNICEF - VenezuelaRan2024 to 2024Enrolled299ConditionsAcute Malnutrition in Childhood, Wasting, Child MalnutritionArmsSimplified protocol, Standard protocol
NCT06792370 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effectiveness of an Alternative Protocol in the Management of Acute Malnutrition in Children Aged 6-59 Months in Burkina Faso: Reduced Dose of RUTF for SAM Children and RUTF Instead of RUSF for MAM Children

TypeinterventionalSponsorInstitut de Recherche en Sciences de la Sante, Burkina FasoRan2025 to 2026Enrolled3,521ConditionsAcute Malnutrition with No ComplicationsArmsready-to-use therapeutic food (for children with MAM), Ready-to-use supplementary food, Ready to Use Therapeutic Food - Reduced dose 1, Ready to Use Therapeutic Food - Standard dose, Ready to Use Therapeutic Food - Reduced dose 2
NCT07592260 narecruitingnot on this mapstarted 2025, after this paper: background citation

OptiMAx: Incentivizing EPI Vaccination Via Distribution of SQ-LNS Nutritional Supplementation to Children From Age 6-11 Months Until 18 Months of Age in Rural Chad and Niger, With a Cost Effectiveness Analysis Protocol for a Research Study Nested in the OptiMA Research Study in Ngouri Health District, Lake Region, Chad and Mirriah Health District, Zinder Region, Niger

TypeinterventionalSponsorAlliance for International Medical ActionRan2025 to 2026Enrolled20,000ConditionsMalnutrition Severe, VaccinationArmssmall quantity lipid-based supplement (SQ-LNS)
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maguy Daures *University of Bordeaux, Inserm, Bordeaux Population Health Research Center, team IDLIC, UMR 1219, Bordeaux, France.ORCID 0000-0003-2878-4524
Kevin Phelan *The Alliance for International Medical Action (ALIMA), Paris, France.
Mariama IssoufouThe Alliance for International Medical Action (ALIMA), Yako, Burkina Faso.
Séni KouandaDépartement biomédical et santé publique, Institut de Recherche en Sciences de la Sante, Ouagadougou, Burkina Faso.
Ousmane SawadogoAssociation KEOOGO, Ouagadougou, Burkina Faso.
Kader IssaleyThe Alliance for International Medical Action (ALIMA), Dakar, Senegal.
Cecile CazesUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, team IDLIC, UMR 1219, Bordeaux, France.
Benjamin SériPACCI research programme, University Hospital of Treichville, Abidjan, Ivory Coast.
Bertine OuaroMinistry of Health, Ouagadougou, Burkina Faso.
Bruno AkpakpoThe Alliance for International Medical Action (ALIMA), Yako, Burkina Faso.
Vincent MendiboureThe Alliance for International Medical Action (ALIMA), Dakar, Senegal.
Susan ShepherdThe Alliance for International Medical Action (ALIMA), Dakar, Senegal.
Renaud BecquetUniversity of Bordeaux, Inserm, Bordeaux Population Health Research Center, team IDLIC, UMR 1219, Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Optimising treatment for acute MAlnutrition (OptiMA) strategy trains mothers to use mid upper arm circumference (MUAC) bracelets for screening and targets treatment to children with MUAC < 125 mm or oedema with one therapeutic food at a gradually reduced dose. This study seeks to determine whether OptiMA conforms to SPHERE standards (recovery rate > 75 %). A single-arm proof-of-concept trial was conducted in 2017 in Yako district, Burkina Faso including children aged 6-59 months in outpatient health centres with MUAC < 125 mm or oedema. Outcomes were stratified by MUAC category at admission. Multivariate survival analysis was carried out to identify variables predictive of recovery. Among 4958 children included, 824 (16·6 %) were admitted with MUAC < 115 mm or oedema, 1070 (21·6 %) with MUAC 115-119 mm and 3064 (61·8 %) with MUAC 120-124 mm. The new dosage was correctly implemented at all visits for 75·9 % of children. Global recovery was 86·3 (95 % CI 85·4, 87·2) % and 70·5 (95 % CI 67·5, 73·5) % for children admitted with MUAC < 115 mm or oedema. Average therapeutic food consumption was 60·8 sachets per child treated. Recovery was positively associated with mothers trained to use MUAC prior to child's admission (adjusted hazard ratio 1·09; 95 % CI 1·01, 1·19). OptiMA was successfully implemented at the scale of an entire district under 'real-life' conditions. Programme outcomes exceeded SPHERE standards, but further study is needed to determine if increasing therapeutic food dosages for the most severely malnourished will improve recovery.

Indexed as

Burkina FasoChild Nutrition DisordersChild, PreschoolDietary SupplementsFemaleFoodGrowth DisordersHumansInfantMaleMultivariate AnalysisProtein-Energy MalnutritionAcute malnutritionChildrenMid upper arm circumferenceWest Africa

Identifiers

PMID31818335
PMCPMC7054246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.